Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

Pulmonx Corporation25 enrolled

Overview

The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments in emphysema patients prior to endobronchial lung volume reduction (ELVR).

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Heterogeneous Emphysema

Interventions

Chartis SystemDEVICE

Assessment of airway flow and pressure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Heterogeneous emphysema as determined by high-resolution CT scan * Scheduled for clinically indicated ELVR procedure Exclusion Criteria: * Hyperexcretive chronic bronchitis or excessive sputum secretion * Active pulmonary infection * Active asthma or lung hyper-responsiveness

Locations (1)

Thoraxklinik am Universitatsklinikum Heidelberg

Heidelberg, Germany

Outcomes

Primary Outcomes

Adverse events

Time frame: Until end of study procedure

Secondary Outcomes

Technical success

Time frame: During procedure and up 1 week post procedure

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.